BACKGROUND: Long-term effectiveness of a dapsone compliance program was assessed in patients with leprosy.
METHODS: The monitoring program consists of urine dapsone/creatinine ratio determination at each visit with subsequent patient feedback and education. Eighty-eight patients receiving dapsone and seen in a leprosy clinic from 1985-1990 were included.
RESULTS: The proportion of patients compliant with dapsone during a given year ranged from 70.0% (1987) to 94.4% (1989). Overall compliance for the 6-year period was 81.6%. This level of compliance was significantly different (P < 0.05) than the baseline compliance in the leprosy clinic of 46.7%.
CONCLUSIONS: Compliance monitoring, combined with active patient involvement, was effective in sustaining high compliance over a 6-year period.
BT - International journal of dermatology C1 - http://www.ncbi.nlm.nih.gov/pubmed/8444536?dopt=Abstract DA - 1993 Mar DO - 10.1111/j.1365-4362.1993.tb02797.x IS - 3 J2 - Int. J. Dermatol. LA - eng N2 -BACKGROUND: Long-term effectiveness of a dapsone compliance program was assessed in patients with leprosy.
METHODS: The monitoring program consists of urine dapsone/creatinine ratio determination at each visit with subsequent patient feedback and education. Eighty-eight patients receiving dapsone and seen in a leprosy clinic from 1985-1990 were included.
RESULTS: The proportion of patients compliant with dapsone during a given year ranged from 70.0% (1987) to 94.4% (1989). Overall compliance for the 6-year period was 81.6%. This level of compliance was significantly different (P < 0.05) than the baseline compliance in the leprosy clinic of 46.7%.
CONCLUSIONS: Compliance monitoring, combined with active patient involvement, was effective in sustaining high compliance over a 6-year period.
PY - 1993 SP - 206 EP - 9 T2 - International journal of dermatology TI - Effectiveness of a dapsone compliance program in leprosy. VL - 32 SN - 0011-9059 ER -